150 related articles for article (PubMed ID: 19059879)
1. Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients.
Tschudi M; Lämmle B; Alberio L
Blood; 2009 Mar; 113(11):2402-9. PubMed ID: 19059879
[TBL] [Abstract][Full Text] [Related]
2. Bivalirudin dosing adjustments for reduced renal function with or without hemodialysis in the management of heparin-induced thrombocytopenia.
Tsu LV; Dager WE
Ann Pharmacother; 2011 Oct; 45(10):1185-92. PubMed ID: 21881032
[TBL] [Abstract][Full Text] [Related]
3. Recommended and actual lepirudin doses in patients with renal insufficiency.
Saxer SB; Smith BS; Gandhi PJ; Tataronis GR; Krikorian SA
Am J Health Syst Pharm; 2003 Dec; 60(24):2588-93. PubMed ID: 14735776
[No Abstract] [Full Text] [Related]
4. Lepirudin in the management of heparin-induced thrombocytopenia.
Gajra A; Husain J; Smith A
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1131-41. PubMed ID: 18680447
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
Kiser TH; Jung R; MacLaren R; Fish DN
Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
[TBL] [Abstract][Full Text] [Related]
6. Safety, efficacy, and dosing requirements of bivalirudin in patients with heparin-induced thrombocytopenia.
Kiser TH; Burch JC; Klem PM; Hassell KL
Pharmacotherapy; 2008 Sep; 28(9):1115-24. PubMed ID: 18752382
[TBL] [Abstract][Full Text] [Related]
7. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies.
Lubenow N; Eichler P; Lietz T; Farner B; Greinacher A
Blood; 2004 Nov; 104(10):3072-7. PubMed ID: 15280202
[TBL] [Abstract][Full Text] [Related]
8. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II).
Schneider T; Heuer B; Deller A; Boesken WH
Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874
[TBL] [Abstract][Full Text] [Related]
9. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia.
Farner B; Eichler P; Kroll H; Greinacher A
Thromb Haemost; 2001 Jun; 85(6):950-7. PubMed ID: 11434701
[TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study.
Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B
Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382
[TBL] [Abstract][Full Text] [Related]
11. Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
Tardy-Poncet B; Charier D; Diconne E; Zeni F; Garraud O; Tardy B; Campos L
Br J Haematol; 2009 Aug; 146(4):456-7. PubMed ID: 19519692
[No Abstract] [Full Text] [Related]
12. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
13. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3.
Lubenow N; Eichler P; Lietz T; Greinacher A;
J Thromb Haemost; 2005 Nov; 3(11):2428-36. PubMed ID: 16241940
[TBL] [Abstract][Full Text] [Related]
14. Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin.
Al-Rossaies A; Alkharfy KM; Al-Ayoubi F; Al-Momen A
Int J Clin Pharm; 2011 Dec; 33(6):997-1001. PubMed ID: 22002684
[TBL] [Abstract][Full Text] [Related]
15. Lepirudin dosing in dialysis-dependent renal failure.
Wittkowsky AK; Kondo LM
Pharmacotherapy; 2000 Sep; 20(9):1123-8. PubMed ID: 10999507
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
Dang CH; Durkalski VL; Nappi JM
Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
[TBL] [Abstract][Full Text] [Related]
17. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis.
Dager WE; White RH
Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140
[TBL] [Abstract][Full Text] [Related]
18. [Lepirudin during cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia].
Boinot C; Lanquetot H; Macchi L; Charrière JM; Menu P
Ann Fr Anesth Reanim; 2003 Jul; 22(7):635-8. PubMed ID: 12946496
[TBL] [Abstract][Full Text] [Related]
19. Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range.
Greinacher A; Eichler P; Lubenow N; Kwasny H; Luz M
Blood; 2000 Aug; 96(3):846-51. PubMed ID: 10910895
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
Bain J; Meyer A
Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
